在髓性恶性瘤中融合基因
Chieh Hwee Ang1, Hein Than1, Tertius T Tuy1
1Department of Haematology, Singapore General Hospital, Singapore 169608, Singapore.
Cancers
|December 17, 2024
概括
由染色体变化产生的融合基因是诊断和治疗急性髓性白血病等髓性恶性瘤的关键. 测序方面的进步揭示了新的融合基因,影响了癌症治疗和生物标志物开发.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 由染色体重排而产生的融合基因在瘤发生过程中至关重要.
- 它们在诊断和预测骨髓瘤恶性瘤方面发挥着至关重要的作用.
- 融合基因是急性髓性白血病 (AML) 风险分层和治疗指导的组成部分.
研究的目的:
- 审查融合基因的分子基础,机制和临床影响.
- 讨论检测融合基因的方法,包括它们的优缺点.
- 通过案例研究,提供对临床挑战的洞察力和通过融合基因治疗髓状瘤恶性瘤的管理.
主要方法:
- 关于融合基因研究的文献综述.
- 分析融合基因的诊断和预后作用.
- 讨论用于融合基因检测的测序技术.
- 在骨髓瘤恶性瘤的临床案例研究的介绍.
主要成果:
- 融合基因对于定义特定的癌症实体至关重要,并具有作为治疗标和生物标记物的潜力.
- 基因组医学和测序创新正在增加新型融合基因的检测.
- 临床案例研究突出了诊断和管理融合基因阳性髓状瘤的实际挑战.
结论:
- 融合基因对于理解和管理骨髓性恶性瘤至关重要.
- 不断发展的诊断技术正在完善融合基因在临床实践中的作用.
- 向融合基因为新型癌症治疗和诊断提供了有希望的途径.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


